Lorena L. Pontes-De Figueiredo

Ribeirao Preto, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

Journal: Haematologica

Published: September 08, 2025

Platelets display immunophenotypic alterations and dysregulated transcriptomic signature in Philadelphia-negative myeloproliferative neoplasms.

Platelets display immunophenotypic alterations and dysregulated transcriptomic signature in Philadelphia-negative myeloproliferative neoplasms.

Journal: Thrombosis research

Published: August 06, 2025

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study.

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study.

Journal: Frontiers in oncology

Published: February 28, 2024

Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.

Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.

Journal: British journal of haematology

Published: May 02, 2023

Bioactive Lipids as Chronic Myeloid Leukemia's Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors.

Bioactive Lipids as Chronic Myeloid Leukemia's Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors.

Journal: Frontiers in immunology

Published: December 20, 2021

Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms.

Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms.

Journal: Medical oncology (Northwood, London, England)

Published: November 23, 2021

STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.

STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.

Journal: Investigational new drugs

Published: September 03, 2021

Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Journal: Frontiers in oncology

Published: February 06, 2021

NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia.

NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia.

Journal: Investigational new drugs

Published: August 24, 2020

Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia.

Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia.

Journal: British journal of haematology

Published: November 05, 2019

C/EBPγ is dispensable for steady-state and emergency granulopoiesis.

C/EBPγ is dispensable for steady-state and emergency granulopoiesis.

Journal: Haematologica

Published: March 24, 2018

Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.

Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 19, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026